Bharat Book

Anesthetic Effect - Pipeline Review, H2 2013

Press Release   •   Dec 09, 2013 12:13 IST

Dec 09, 2013 : Bharat Book Bureau presents the new report, on 'Anesthetic Effect - Pipeline Review, H2 2013'  also reviews key players involved in the therapeutic development for Anesthetic Effect. Anesthetic Effect - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Anesthetic Effect.
- A review of the Anesthetic Effect products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Anesthetic Effect pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Anesthetic Effect.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Anesthetic Effect pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned

Merck & Co., Inc.
Physica Pharma
Lipicard Technologies Limited
Novaliq GmbH
Maruishi Pharmaceutical Co., Ltd.

Table of contents :

Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Anesthetic Effect Overview 7
Therapeutics Development 8
An Overview of Pipeline Products for Anesthetic Effect 8
Anesthetic Effect Therapeutics under Development by Companies 10
Anesthetic Effect Therapeutics under Investigation by Universities/Institutes 11
Late Stage Products 12
Comparative Analysis 12
Early Clinical Stage Products 13
Comparative Analysis 13
Discovery and Pre-Clinical Stage Products 14
Comparative Analysis 14
Anesthetic Effect Therapeutics - Products under Development by Companies 15
Anesthetic Effect Therapeutics - Products under Investigation by Universities/Institutes 16
Companies Involved in Anesthetic Effect Therapeutics Development 17
Merck & Co., Inc. 17
Physica Pharma 18
Lipicard Technologies Limited 19
Novaliq GmbH 20
Maruishi Pharmaceutical Co., Ltd. 21
Anesthetic Effect - Therapeutics Assessment 22
Assessment by Monotherapy Products 22
Assessment by Combination Products 23
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
sugammadex sodium - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
(tetracaine + oxymetazoline hydrochloride) - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
MR-04-A-3 - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
MR-04-A-3 - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Program For Anesthesia - Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
propofol Microemulsion - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
ADV-6209 - Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
LT-1121 - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
LT-1123 - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
SGE-202 - Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
Ketamine Analogues - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
Next Generation Anesthetic - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
Anesthetic Effect Therapeutics - Drug Profile Updates 42
Anesthetic Effect Therapeutics - Discontinued Products 43
Anesthetic Effect Therapeutics - Dormant Products 44
Anesthetic Effect - Product Development Milestones 45
Featured News & Press Releases 45
Aug 07, 2013: gIcare Pharma begins phase IIa trial of GIC-1001 for colonic analgesia 45
Nov 05, 2012: Paion's Partner Ono Pharma Intiates Phase II/III Study With Short-acting Anaesthetic/Sedative Remimazolam In Japan 45
Oct 30, 2012: Powder Pharma Submits Application For FDA Approval Of Zingo Manufacturing Facility In New Hong Kong 46
May 14, 2012: Ono Pharma Announces Phase II Study Results Of ONO-2745/CNS 7056 46
Oct 14, 2011: APP Pharmaceuticals Announces Increased Availability Of APP Diprivan And APP Propofol 1% 47
May 31, 2011: PAION Receives Second Milestone Payment Of $3m From Ono Pharmaceutical Through Start Of Japanese Phase II With Remimazolam 47
Nov 22, 2010: PAION Reports Positive Results Of CNS 7056 In Phase IIb Study In Colonoscopy 48
Sep 27, 2010: PAION Completes Phase IIb Study With CNS 7056 49
Aug 02, 2010: PAION Announces Recruitment Of Phase IIb Trial With CNS 7056 50
Apr 27, 2010: Paion Reaches Agreement With FDA On Phase IIb Study Design For CNS 7056 In Patients Undergoing Colonoscopy 50

For more information kindly visit : http://www.bharatbook.com/Healthcare-market-research-reports/Anesthetic-Effect-Pipeline-Review-H2-20131.html

Related link :  http://www.bharatbook.com/market-research-report/pharmaceuticals-and-healthcare.html

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com 
Website: www.bharatbook.com 
Follow us on twitter: https://twitter.com/researchbook 
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau 
Our Blog : http://blog.bharatbook.com/ 


Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.